XBiotech Inc. (NASDAQ:XBIT – Get Rating) was the target of a large growth in short interest in May. As of May 15th, there was short interest totalling 83,800 shares, a growth of 23.1% from the April 30th total of 68,100 shares. Approximately 0.5% of the shares of the stock are sold short. Based on an […]
StockNews.com initiated coverage on shares of XBiotech (NASDAQ:XBIT – Get Rating) in a research report released on Thursday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. XBiotech Stock Up 1.5 % Shares of XBIT opened at $5.47 on Thursday. The company’s fifty day moving average is $3.70 and its 200-day moving […]
StockNews.com assumed coverage on shares of XBiotech (NASDAQ:XBIT – Get Rating) in a research report released on Thursday. The firm issued a hold rating on the biopharmaceutical company’s stock. XBiotech Price Performance XBiotech stock opened at $5.47 on Thursday. XBiotech has a 12 month low of $3.00 and a 12 month high of $6.49. The […]
XBiotech Believes its Drug Candidate Natrunix Could Revolutionize Arthritis TreatmentAUSTIN, Texas, May 22, 2023 (GLOBE NEWSWIRE) XBiotech Inc. (NASDAQ: XBIT) today reports that the FDA's Division of
StockNews.com started coverage on shares of XBiotech (NASDAQ:XBIT – Get Rating) in a research note released on Wednesday. The firm issued a hold rating on the biopharmaceutical company’s stock. XBiotech Trading Down 1.8 % Shares of XBiotech stock opened at $4.95 on Wednesday. The company’s 50-day moving average price is $3.50 and its two-hundred day […]